Advertisement

Responsive Advertisement
LAMEA to maintain the top status till 2026, North America to grow at the third highest CAGR
North America accounted for around three-fifths share of the global infusion pumps & accessories market in 2021.
The oral segment to maintain its leadership position during the forecast period
The hospitals segment to maintain its dominant share during the forecast period
During the pandemic, egg donation treatments are cancelled and frozen embryos are preserved for later use.
Growth of the global plasma therapy market is majorly driven by rise in prevalence of life-threatening diseases
High cost of software associated with infection surveillance solutions hinders the market growth.
North America segment holds a dominant position in 2018 and would continue to maintain the lead over the forecast period
surge in prevalence of chronic and genetic diseases drive the growth of the global prime editing and CRISPR market
Azoles projected to be the primary drug type in the near future